NKX3-1 and Familial prostate cancer: The clinical implications of our study are that there is likely a molecular basis for differences in bladder fibrosis observed between males and females and that pharmacologic approaches to modulate NKX3.1 in prostate cancer could be extended to treat obstructive uropathies.